We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,598
Reduced
4,167
Closed
928

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLACU
5376
DELISTED
Social Leverage Acquisition Corp I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
SLACU
$193K ﹤0.01%
19,360
+3,889
+25% +$38.9K
IFFT
5377
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
$193K ﹤0.01%
3,812
+614
+19% +$30.7K
DBEZ icon
5378
Xtrackers MSCI Eurozone Hedged Equity ETF
DBEZ
$77M
$192K ﹤0.01%
5,084
-1,404
-22% -$52.8K
HYLN icon
5379
Hyliion Holdings
HYLN
$690M
$192K ﹤0.01%
16,490
+2,657
+19% +$27.8K
UCC icon
5380
ProShares Ultra Consumer Discretionary
UCC
$10.6M
$192K ﹤0.01%
3,776
+1,440
+62% +$71K
VBIV
5381
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$192K ﹤0.01%
1,910
-16,109
-89% -$1.57M
DNLI icon
5382
Denali Therapeutics
DNLI
$3.97B
$191K ﹤0.01%
2,437
-27,792
-92% -$1.72M
OLP
5383
One Liberty Properties
OLP
$527M
$191K ﹤0.01%
6,729
-1,446
-18% -$37.4K
RIGL icon
5384
Rigel Pharmaceuticals
RIGL
$750M
$191K ﹤0.01%
4,382
-27,093
-86% -$1.02M
BNKU
5385
DELISTED
MicroSectorsTM U.S. Big Banks Index 3X Leveraged ETNs
BNKU
$191K ﹤0.01%
+3,636
New +$191K
ANDE icon
5386
Andersons Inc
ANDE
$2.22B
$190K ﹤0.01%
6,218
-14,961
-71% -$451K
CSTM icon
5387
CALL
Constellium
CSTM
$3.99B
$190K ﹤0.01%
+10,000
New +$172K
DJUL icon
5388
FT Vest US Equity Deep Buffer ETF July
DJUL
$457M
$190K ﹤0.01%
5,839
+5,127
+720% +$166K
MCRB icon
5389
Seres Therapeutics
MCRB
$48.9M
$190K ﹤0.01%
399
-11
-3% -$4.64K
NGD
5390
PUT
DELISTED
New Gold Inc
NGD
$190K ﹤0.01%
105,100
+44,100
+72% +$83.1K
UROY
5391
Uranium Royalty Corp
UROY
$1.58B
$190K ﹤0.01%
+63,338
New +$189K
WERN icon
5392
Werner Enterprises
WERN
$2.25B
$190K ﹤0.01%
4,255
+1,453
+52% +$67.8K
ABUS icon
5393
Arbutus Biopharma
ABUS
$915M
$189K ﹤0.01%
62,310
-10,805
-15% -$33.5K
CLRMU
5394
DELISTED
Clarim Acquisition Corp. Unit
CLRMU
$189K ﹤0.01%
18,986
+729
+4% +$7.26K
VTAQU
5395
DELISTED
Ventoux CCM Acquisition Corp. Unit
VTAQU
$189K ﹤0.01%
18,068
-350
-2% -$3.68K
MMAC
5396
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$189K ﹤0.01%
6,927
+4,844
+233% +$105K
LMAT icon
5397
LeMaitre Vascular
LMAT
$1.86B
$188K ﹤0.01%
3,090
-6,440
-68% -$342K
MCB icon
5398
Metropolitan Bank Holding Corp
MCB
$1.15B
$188K ﹤0.01%
3,124
+1,867
+149% +$114K
CNR
5399
Core Natural Resources Inc
CNR
$4.45B
$188K ﹤0.01%
10,182
-5,215
-34% -$70.1K
COLIU
5400
DELISTED
Colicity Inc. Units
COLIU
$188K ﹤0.01%
18,693
+3,693
+25% +$37.2K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 928 positions and reducing 4,167 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 928 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.